Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.10.0.1
Accrued Expenses
9 Months Ended
Dec. 31, 2018
Payables and Accruals [Abstract]  
Accrued Expenses

NOTE 6 ACCRUED EXPENSES

 

A summary of the accrued expenses as of December 31, 2018 and March 31, 2018 is as follows:

 

    As of
December 31, 2018
    As of
March 31, 2018
 
Vendors - clinical trials   $ -     $ 497,577  
Professional fees     67,420       492,250  
Income taxes payable     154,300       154,300  
Employee salaries and benefits     34,337       104,110  
Due to former owners, related to acquisition     34,268       33,124  
Other     34,274       9,525  
                 
    $ 324,599     $ 1,290,886